Medify

Medify is a healthcare technology company focused on delivering innovative solutions that clarify medical information for both healthcare professionals and patients, enhancing communication, engagement, and access to vital health resources. Founded in 2010 in Seattle, US, Medify specializes in innovative healthcare technologies. The company was acquired by Alliance Health Networks in May 2012. The founding team includes Henry Scott, Peter Krol, and Rene Louis, with Henry Scott serving as CEO.

Medify specializes in providing innovative healthcare solutions that clarify medical information for both professionals and patients. Their core offerings include a suite of digital tools designed to streamline healthcare communication, enhance patient engagement, and improve access to health resources. Key functionalities include a user-friendly interface for consolidating medical data, facilitating telehealth consultations, and supporting electronic health record (EHR) integration. Medify's services primarily cater to hospitals, clinics, and individual practitioners across North America and Europe, aiming to improve healthcare quality through clearer, more accessible information.

Medify generates revenue through a multi-faceted transaction structure that includes subscription-based models for their software solutions and partnerships with healthcare institutions. Clients typically pay annually or monthly for access to the platform, which features customizations for specific needs. The company also collaborates with hospitals and healthcare providers, offering tailored packages that include training and support services. Their flagship product is critical in driving revenue and establishing the company in the digital healthcare sector.

Medify plans to leverage its recent funding from the Series A round, which raised USD 1. 80 mn, to enhance product offerings and expand into new markets. The company is currently focused on developing additional digital tools to improve health information clarity and aims to enter additional markets in Europe and Asia by 2024. The recent funding will also support the development and launch of these new products.